Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
Steffen Naegel, Mark ObermannDepartment of Neurology, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, GermanyAbstract: Migraine is a very common disorder characterized by the combination of typical headache with associated autonomic symptoms and/or the presence of aura. Considerable adva...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d98a33ce43c74944b5851239c03d8138 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d98a33ce43c74944b5851239c03d8138 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d98a33ce43c74944b5851239c03d81382021-12-02T01:03:03ZTopiramate in the prevention and treatment of migraine: efficacy, safety and patient preference1176-63281178-2021https://doaj.org/article/d98a33ce43c74944b5851239c03d81382009-12-01T00:00:00Zhttp://www.dovepress.com/topiramate-in-the-prevention-and-treatment-of-migraine-efficacy-safety-a3874https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Steffen Naegel, Mark ObermannDepartment of Neurology, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, GermanyAbstract: Migraine is a very common disorder characterized by the combination of typical headache with associated autonomic symptoms and/or the presence of aura. Considerable advances have been made in recent years to understand the pathophysiology of migraine, which has led to improved treatment options for the acute migraine attack as well as migraine prophylaxis. Unfortunately, preventive treatment is often insufficient to decrease migraine frequency substantially or is not well tolerated. Topiramate is an antipileptic drug with a complex mode of action which has proven its efficacy and safety in the prophylactic treatment of episodic migraine in a number of randomized controlled clinical trials. Topiramate is also effective in treating patients with chronic migraine. It has little pharmacological interaction with other drugs and is generally well tolerated by patients.Keywords: migraine, antiepileptic drugs, topiramate Steffen NaegelMark ObermannDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2010, Iss Issue 1, Pp 17-28 (2009) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Steffen Naegel Mark Obermann Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
description |
Steffen Naegel, Mark ObermannDepartment of Neurology, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, GermanyAbstract: Migraine is a very common disorder characterized by the combination of typical headache with associated autonomic symptoms and/or the presence of aura. Considerable advances have been made in recent years to understand the pathophysiology of migraine, which has led to improved treatment options for the acute migraine attack as well as migraine prophylaxis. Unfortunately, preventive treatment is often insufficient to decrease migraine frequency substantially or is not well tolerated. Topiramate is an antipileptic drug with a complex mode of action which has proven its efficacy and safety in the prophylactic treatment of episodic migraine in a number of randomized controlled clinical trials. Topiramate is also effective in treating patients with chronic migraine. It has little pharmacological interaction with other drugs and is generally well tolerated by patients.Keywords: migraine, antiepileptic drugs, topiramate |
format |
article |
author |
Steffen Naegel Mark Obermann |
author_facet |
Steffen Naegel Mark Obermann |
author_sort |
Steffen Naegel |
title |
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
title_short |
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
title_full |
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
title_fullStr |
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
title_full_unstemmed |
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
title_sort |
topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference |
publisher |
Dove Medical Press |
publishDate |
2009 |
url |
https://doaj.org/article/d98a33ce43c74944b5851239c03d8138 |
work_keys_str_mv |
AT steffennaegel topiramateinthepreventionandtreatmentofmigraineefficacysafetyandpatientpreference AT markobermann topiramateinthepreventionandtreatmentofmigraineefficacysafetyandpatientpreference |
_version_ |
1718403348137246720 |